PL EN


Preferences help
enabled [disable] Abstract
Number of results
2017 | 28 | 109 | 228-236
Article title

The role of adenosine a2a receptors in antidepressant activity in an experimental animal model of depression

Content
Title variants
Languages of publication
EN
Abstracts
EN
Intensive studies on the role of adenosine A2A receptors in Parkinson’s disease have been carried out for many years,. These studies have indicated that the antagonists of these receptors not only alleviate motor deficits but also exhibit neuroprotective effects in various animal models. Little is known about the role of these receptors in ailments accompanying Parkinson’s disease, such as depression and anxiety. This paper provides a summary of existing research on the role of A2A receptors in comorbid depression in Parkinson’s disease.
Publisher

Year
Volume
28
Issue
109
Pages
228-236
Physical description
Contributors
author
  • Department of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University, Medical College, Medyczna 9, 30-688 Cracow, Poland, gogol67@interia.pl
author
author
References
  • 1. Chen, J-F., Sonsalla, P.K., Pedata, F., Melani, A., Domenici, M.R., Popoli, P.; Prog Neurobiol, 2007, 83, 310–331.\
  • 2. Pytka, K., Zygmunt, M., Filipek, B.; Postepy Hig Med Dosw, 2013, 67, 700–708.
  • 3. Shen, H-Y., Chen, J.F.; Current Neuropharmacol, 2009, 7, 195–206.
  • 4. Kadowaki, H.T., Kobayashi, M., Mori, A., Jenner, P., Kanda, T.; Psychopharmacol, 2013, 230, 345– 352.
  • 5. Pinna, A.; Exp Opin Investig Drugs, 2009, 18,1619–1631.
  • 6. Fredholm, B.B., Ijzerman, A.P., Jacobson, K.A., Linden, J., Müller, Ce.; Pharmacol Rev, 2011, 63, 1–33.
  • 7. Dixon, A.K., Gubitz, A.K., Sirinathsinghji, D.J., Richardson, P.J., Freeman, T.C.; Br J Pharmacol, 1996, 118(6), 1461–1468.
  • 8. Berck, M., Plein, H., Ferreira, D., Jersky, B.; Eur. Neuropsychopharmacology 2001, 11, 183–186.
  • 9. Porsolt, R.D., Le Pchon, M., Jalfre, M.; Nature, 1978, 266, 730–732.
  • 10. Kaster, M.P., Rosa, A.O., Rosso, M.M., Goulart, E.C., Santos, A.R., Rodrigues, A.L.; Neurosci Lett, 2004, 355, 21–24.
  • 11. Kaster, M.P., Budni, J., Santos, A.R., Rodrigues, A.L.; Eur J Pharmacol, 2007, 576, 91–98.
  • 12. Kaster, M.P., Rosa, A.O., Santos, A., Rodrigues, A.L.; Int J Neuropsychopharmacol, 2005, 8, 601– 606.
  • 13. Gołembiowska, K., Dziubina, A.; Naunyn Schmiedebergs Arch Pharmacol, 2001, 363, 663– 670.
  • 14. Pellicano, C., Wu, K., Loane, C., Turkheimer, F.E., Molly, S., Brooks, D.J.; Neuropsychiat Dis Treat, 2007, 3, 145–151.
  • 15. Palhagen, S.E., Carlsson, M., Curman, E., Walinde, J., Granerus, A.K..; Acta Neurol Scand, 2008,117, 295–304.
  • 16. Lieberman, A.; Acta Neurol Scand, 2006, 113, 1–8.
  • 17. Kuopio, A.M., Marttila, R.J., Toivonen, M., Rinne, U.K.; Mov Disord, 2000, 15, 216–223.
  • 18. Riedel, O., Klotsche, J., Spottke, A., Deuschl, G., Förstl, H., Henn, F.; J Neurol, 2010, 257, 1073–1082.
  • 19. Groenewegen, H.J.; CNS Spectr, 2007, 12, 887–892.
  • 20. Kuter, K., Kolasiewicz, W., Gołembiowska, K., Dziubina, A., Schulze, G., Berghauzen, K.; Pharmacol Rep, 2011, 63,1383–1392.
  • 21. Brown, A.S., Gershon, S.; J Neural Transm Gen Sect, 1993, 1, 75–109.
  • 22. Hesse, S., Meyer, P.M., Strecker, K., Bartel, H., Wegner, F., Oehlwein, C.; Eur J Nucl Med Mol Imaging, 2009, 36, 428–435.
  • 23. Remy, P., M. Doder, A. Lees, N. Turjanski, And D. Brooks.; 2005, 128, 1314–1322.
  • 24. Joutsa, J., Rinne, J.O., Eskola, O., Kaasinen, V.; J Parkinsons Dis, 2013, 3, 325–329.
  • 25. Mayeux, R., Stern, Y., Cote, L., Williams, J.B.; Neurology, 1984, 34, 642–646.
  • 26. Pollitis, M., Wu, K., Loane, C., Turkheimer, F.E., Molly, S., Brooks, D.J.; Neurology, 2010, 75, 1920–27.
  • 27. Kostić, V.S., Agosta, F., Galantucci, S., Spica, V., Jecmenica-Lukic, M.; Neurology, 2010, 75, 857– 863.
  • 28. Chagas, M.H.N., Linares, I.M.P., Garcia, G.J., Hallak, J.E.C., Tumas, V., Crippa, J.A.S.; Int Psychogeriatr, 2013, 2,1–9.
  • 29. Hemmerle, A.M., Herman, J.P., Seroogy, K.B.; Exp Neurol, 2012, 233, 79–86.
  • 30. Müller, T., Welnic, J., Muhlack, S.; J Neural Transm, 2007, 114, 347–350.
  • 31. Huber, T.; Pharmacopsychiatry, 1999, 32, 47–55.
  • 32. Leentjens, A.F.; Drugs, 2011, 71, 273–286.
  • 33. Leentjens, A.F., Vreeling, F.W., Luijckx, G.J., Verhy, F.R.; Int J Geriatr Psychiatry, 2003, 18, 552–554.
  • 34. Ceravolo, R., Nuti, A., Piccinni, A., Dell’agnello, G., Bellini, G., Gambaccini, G.; Neurology, 2000, 55, 1216–1218.
  • 35. Andersen, J., Aabro, V., Gulmann, N., Hjelmsted, A., Pedersen, H.E.; Acta. Neurol. Scand. 1980, 62, 210–219.
  • 36. El Yacoub, M., Costentin, J., Vaugeois, J.M.; Neurology, 2003, 61, 82–87.
  • 37. Bogenpohl, J.W., Ritter, S. L., Hall, R.A., Smith. Y.; J Comp Neurol, 2012, 520, 570–589.
  • 38. Rosin, D.L., Robeva, A., Woodard, R.L., Guyenet, P.G., Linden, J.; J Comp Neurol, 1998, 401, 163–186.
  • 39. Fink, J.S., Weaver, D.R., Rivkees, S.A., Peterfreund, R.A., Pollack, A.E. Adler, E.M.; Mol Brain Res, 1992, 14, 186–195.
  • 40. Xu, K., Bastia, E., Schwarzschild, M.; Pharmacol Ther, 2005, 105, 267–310.
  • 41. Lerner, T.N., Horne, E.A., Stella, N., Kreitzer, A.C.; J Neurosci, 2010, 30, 2160–64.
  • 42. Hillion, J., Canals, M., Torvinen, M., Casado, V., Scott, R., Terasmaa, A., Hansson, A., Watson, S., Olah, M.E., Mallol, J., Canela, E.I., Zoli, M., Agnati, L.F., Ibanez, C.F., Lluis, C., Franco, R., Ferre, S., Fuxe, K.; J Biol Chem, 2002, 277, 18091– 18097.
  • 43. Gołembiowska, K., Dziubina, A.; Brain Res, 2004, 298, 208–217.
  • 44. Kurokawa, M., I.P. Kirk, K.A. Kirkpatrick, H. Kase, And P.J. Richardson.; Br J Pharmacol, 1994, 113, 43–48.
  • 45. Ledent, C., Vaugeosis, J.M., Schiffmann, S.N., Pedrazzini, T., El Yacoubi, M.; Nature, 1997, 388, 674–678.
  • 46. Crema, L.M., Pettenuzzo, L.F., Schlabitz, M., Diehl, L., Hoppe, J., Mestriner, R., Laureano, D., Salbego, C., Dalmaz, C., Vendite, D.; Physiol Behav, 2013, 109, 1–7.
  • 47. Rasheed, N., Ahmad, A., Pandey, C.P., Chaturvedi, R.K., Lohani, M., Palit, G.;Neurochem Res, 2010, 35, 22–32.
  • 48. Okada, M., Nutt, D.J., Murakami, T., Zhu, G., Kamata, A., Kawata Y.; J Neurosci, 2001, 21, 628– 640.
  • 49. Batalha,V.L., Pego, J.M., Fontinha, B.M., Costenla, A.R., Valadas, J.S., Baqi, Y.; Mol. Psych. 2013, 18, 320–331.
  • 50. Chen, B., Dowlatshahi, D., Macqueen, G.M., Wang, J.F., Young, L.T.; Biol Psychiatry, 2001, 50, 260–265.
  • 51. Shirayama, Y., Chen, A.C., Nakagawa, S., Russel, D.S., Duman, R.S.; J Neurosci, 2002, 22, 3251–3261.
  • 52. Sebastiao, A.M., Ribeiro, J.A.; Br J Pharmacol, 2009, 158, 15–22.
  • 53. Potenza, R.L., Tebano, M.T., Martire, A., Domenici, M.R., Pepponi, R., Armida, M.; Purinergic Signal, 2007, 3, 333–338.
  • 54. Jeon, S.J., Rhee, S.Y., Ryu, J.H., Cheong, J.H., Kwon, K., Yang, S.I.; Neurochem Res, 2011, 36, 2259–2269.
  • 55. Tebano, M.T., Martire, A., Potenza, R.L.; J Neurochem, 2008, 104, 279–286.
  • 56. Shook, B.C., Jackson, P.F.; ACS Chem Neurosci, 2011, 2, 555–567.
  • 57. Ochi, M., Koga, K., Kurokawa, M., Kase, H.,
  • Nakamura, J., Kuwana, Y.; Neuroscience, 2000, 100, 53–62.
  • 58. Trevitt, J., Vallance, Ch., Harris, A., Goode, T.; Pharmacol Biochem Behav, 2009, 92, 521–527.
  • 59. Kanda, T., Jackson, M.J., Smith, L.A., Pearce, R.K., Nakamura, J., Kase, H.; Exp Neurol, 2000, 162, 321–327.
  • 60. Bibbiani, F., Oh, J.D., Petzer, J.P., Castagnoli, N.Jr., Chen, J.F., Schwarzschild, M.A.; Exp Neurol, 2003, 184, 285–294.
  • 61. Morelli, M., Di Paolo, T., Wardas, J., Calon, F., Xiao, D., Schwarzschild, M.A.; Prog Neurobiol, 2007, 83, 293–309.
  • 62. Pinna, A., Pontis, S., Borsini, F., Morelli, M.; Synapse, 2007, 61, 606–614.
  • 63. Hodgson, R.A., Bedard, P.J., Varty, G.B., Kazdoba, T.M., Di Paolo, T., Grzelak, M.E.; Exp Neurol, 2010, 225, 384–390.
  • 64. Simola, N., Fenu, S., Baraldi, P.G., Tabrizi, M.A., Morelli, M.; Exp Neurol, 2004, 1, 182–188.
  • 65. Sarges, R., Howard, H.R., Browne, R.G., Lebel, L.A., Seymour, P.A., Koe, B.K.; J Med Chem, 1990, 33, 2240–2254.
  • 66. Yamada, K., Kobayashi, M., Mori, A., Jenner, P., Kanda, T.; Pharmacol Biochem Behav, 2013, 114- 115, 23–30.
  • 67. Hodgson, R.A., Bertorelli, R., Varty, G.B., Lachowicz, J.E., Forlani, A., Fredduzzi, S.; J Pharmacol Exp Ther, 2009, 330, 294–303.
  • 68. Gołembiowska, K., Dziubina, A.; Neuropharmacology, 2004, 47, 414–426.
  • 69. Yamada, K., Kobayashi, M., Shiozaki, S., Ohta, T., Mori, A., Jenner, P.; Psychopharmacology, 2014, 231, 2839–2849.
  • 70. Kano, O., Ikeda, K., Kiyozuka, T., Iwamato, K., Ito, H., Kawase, Y.; Neuropsychiatr Dis Treat, 2000, 4, 707–710.
  • 71. Pechlivanowa, D.M., Tchekalarova, J.D., Alova, L.H., Petkov, V.N., Rumen, P.Y., Krassimira, S.; Behav Pharmacol, 2012, 23, 339–347
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-8dc56564-8628-4a67-952e-f44912c9fd2d
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.